Prof. Dr. Rainer Schulz

Cited by

	All	Since 2019
Citations	38724	13640
h-index	100	62
i10-index	345	229

2600

1300

650

1950

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024132 214 207 322 207 340 380 370 477 552 627 787 886 1066 1128 1317 2039 1870 2063 1799 1919 1856 1940 2014 2228 2237 2578 2293 2314 1955

Public access

View all

145 articles

22 articles

available

not available

Based on funding mandates

Co-authors

Gerd HeuschProfessor, Universität Duisburg-EssenVerified email at uk-essen.de
Péter FerdinandySemmelweis University, Budapest; Pharmahungary Group, Szeged, HungaryVerified email at pharmahungary.com
Sandrine LecourProfessor, University of Cape TownVerified email at uct.ac.za
Sean Michael DavidsonUniversity College LondonVerified email at ucl.ac.uk
Rosalinda Madonna"G. D'Annunzio" University, Chieti, Italy; University of Texas Medical School and Texas HeartVerified email at unich.it
Hans Erik BøtkerProfessor in cardiovascular medicine and interventional cardiologyVerified email at dadlnet.dk
Ioanna AndreadouProfessor of Pharmacology, National and Kapodistrian University of Athens, School ofVerified email at pharm.uoa.gr
Tienush RassafDirektor der Klinik für Kardiologie und Angiologie, UniversityVerified email at uk-essen.de
Michel Ovizeprofesseur de physiologie cardiologie, université claude bernard de lyonVerified email at chu-lyon.fr
Joost SluijterProfessor Cellular and Translational Cardiology, UMC Utrecht, the NetherlandsVerified email at umcutrecht.nl
Zoltan Giriczsenior research associate, Semmelweis UniversityVerified email at net.sote.hu
Gary F. BaxterProfessor of Pharmacology, School of Pharmacy & Pharmaceutical Sciences, Cardiff university, UKVerified email at cardiff.ac.uk
Cinzia PerrinoFederico II UniversityVerified email at unina.it
Denise Hilfiker-KleinerProfessor of molecular cardiology and cardiovascular side effects in oncologic therapiesVerified email at uni-marburg.de
Luc LeybaertGhent universityVerified email at ugent.be
Péter BencsikUniversity of Szeged & Pharmahungary GroupVerified email at med.u-szeged.hu
James M. DowneyProfessor of Physiology, University of South AlabamaVerified email at southalabama.edu
Andreas DaiberProfessor Molecular Cardiology, Cardiology 1, University Medical Center MainzVerified email at bioredox.com
Jakob Vinten-JohansenProfessor Emeritus, Emory UniversityVerified email at emory.edu
Muhammad AslamJustus Liebig University, Giessen, GermanyVerified email at physiologie.med.uni-giessen.de

Prof. Dr. Rainer Schulz

JLU Giessen

Verified email at physiologie.med.uni-giessen.de - Homepage

Physiologie


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy D Hilfiker-Kleiner, K Kaminski, E Podewski, T Bonda, A Schaefer, K Sliwa, ... Cell 128 (3), 589-600, 2007	1049	2007
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning P Ferdinandy, R Schulz, GF Baxter Pharmacological reviews 59 (4), 418-458, 2007	1024	2007
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals P Kleinbongard, A Dejam, T Lauer, T Rassaf, A Schindler, O Picker, ... Free Radical Biology and Medicine 35 (7), 790-796, 2003	710	2003
Red blood cells express a functional endothelial nitric oxide synthase P Kleinbongard, R Schulz, T Rassaf, T Lauer, A Dejam, T Jax, I Kumara, ... Blood 107 (7), 2943-2951, 2006	694	2006
Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning P Ferdinandy, DJ Hausenloy, G Heusch, GF Baxter, R Schulz Pharmacological reviews 66 (4), 1142-1174, 2014	689	2014
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of … M Ovize, GF Baxter, F Di Lisa, P Ferdinandy, D Garcia-Dorado, ... Cardiovascular research 87 (3), 406-423, 2010	644	2010
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week SM Davidson, P Ferdinandy, I Andreadou, HE Bøtker, G Heusch, B Ibáñez, ... Journal of the American College of Cardiology 73 (1), 89-99, 2019	635	2019
Nitric oxide in myocardial ischemia/reperfusion injury R Schulz, M Kelm, G Heusch Cardiovascular research 61 (3), 402-413, 2004	632	2004
Cardioprotection: nitric oxide, protein kinases, and mitochondria G Heusch, K Boengler, R Schulz Circulation 118 (19), 1915-1919, 2008	543	2008
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure P Kleinbongard, G Heusch, R Schulz Pharmacology & therapeutics 127 (3), 295-314, 2010	532	2010
Coronary microembolization: from bedside to bench and back to bedside G Heusch, P Kleinbongard, D Böse, B Levkau, M Haude, R Schulz, ... Circulation 120 (18), 1822-1836, 2009	518	2009
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid … G Theilmeier, C Schmidt, J Herrmann, P Keul, M Schäfers, I Herrgott, ... Circulation 114 (13), 1403-1409, 2006	499	2006
Measurement of regional myocardial blood flow with multiple colored microspheres. P Kowallik, R Schulz, BD Guth, A Schade, W Paffhausen, R Gross, ... Circulation 83 (3), 974-982, 1991	464	1991
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion K Boengler, D Hilfiker-Kleiner, G Heusch, R Schulz Basic research in cardiology 105, 771-785, 2010	461	2010
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury D Hilfiker-Kleiner, A Hilfiker, M Fuchs, K Kaminski, A Schaefer, B Schieffer, ... Circulation research 95 (2), 187-195, 2004	459	2004
ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function HK Eltzschig, T Eckle, A Mager, N Küper, C Karcher, T Weissmüller, ... Circulation research 99 (10), 1100-1108, 2006	440	2006
The myocardial JAK/STAT pathway: from protection to failure K Boengler, D Hilfiker-Kleiner, H Drexler, G Heusch, R Schulz Pharmacology & therapeutics 120 (2), 172-185, 2008	437	2008
Signal transduction of ischemic preconditioning R Schulz, MV Cohen, M Behrends, JM Downey, G Heusch Cardiovascular research 52 (2), 181-198, 2001	424	2001
Loss of cardioprotection with ageing K Boengler, R Schulz, G Heusch Cardiovascular research 83 (2), 247-261, 2009	416	2009
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection HE Bøtker, D Hausenloy, I Andreadou, S Antonucci, K Boengler, ... Basic research in cardiology 113, 1-73, 2018	409	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors